Chiu Liang-Chun, Lin Chih-Wen, Li Hung-Ju, Chen Jian-Han, Chuang Fu-Cheng, Lin Sheng-Fung, Chang Yu, Su Yu-Chieh
Department of Obstetrics and Gynecology, E-Da Dachang Hospital, I-Shou University, Kaohsiung 807, Taiwan.
School of Medicine, College of Medicine, I-Shou University, Kaohsiung 824, Taiwan.
J Clin Med. 2023 Feb 10;12(4):1417. doi: 10.3390/jcm12041417.
A continuous increase in follicular lymphoma has been observed in Taiwan, Japan, and South Korea over the last few decades. This study aimed to evaluate the difference in incidence trends of follicular lymphoma in Taiwan, Japan, and South Korea between 2001 and 2019. The data for the Taiwanese populations was obtained from the Taiwan Cancer Registry Database, and those for the Japanese and Korean population were retrieved from the Japan National Cancer Registry and some additional reports, both of which included population-based cancer registry data, from Japan and Korea. Follicular lymphoma accounted for 4231 cases from 2002-2019 in Taiwan, 3744 cases from 2001-2008 and 49,731 cases from 2014-2019 in Japan; and 1365 cases from 2001-2012 and 1244 cases from 2011-2016 in South Korea. The annual percentage change for each time period was 3.49% (95% confidence interval: 2.75-4.24%) in Taiwan, 12.66% (95% confidence interval [CI]: 9.59-15.81%) and 4.95% (95% CI: 2.14-7.84%) in Japan, and 5.72% (95% CI: 2.79-8.73%) and 7.93% (95% CI: -1.63-18.42%) in South Korea. Our study confirms that the increasing trends of follicular lymphoma incidence in Taiwan and Japan have been remarkable in recent years, especially the rapid increase in Japan between 2014 and 2019; however, there was no significant in-crease from 2011 to 2015 in South Korea.
在过去几十年中,台湾、日本和韩国的滤泡性淋巴瘤发病率持续上升。本研究旨在评估2001年至2019年期间台湾、日本和韩国滤泡性淋巴瘤发病率趋势的差异。台湾人群的数据来自台湾癌症登记数据库,日本和韩国人群的数据则从日本国家癌症登记处及其他一些报告中获取,这些报告均包含日本和韩国基于人群的癌症登记数据。2002年至2019年台湾有4231例滤泡性淋巴瘤病例,2001年至2008年日本有3744例,2014年至2019年有49731例;2001年至2012年韩国有1365例,2011年至2016年有1244例。台湾各时间段的年变化百分比为3.49%(95%置信区间:2.75 - 4.24%),日本为12.66%(95%置信区间[CI]:9.59 - 15.81%)和4.95%(95% CI:2.14 - 7.84%),韩国为5.72%(95% CI:2.79 - 8.73%)和7.93%(95% CI: - 1.63 - 18.42%)。我们的研究证实,近年来台湾和日本滤泡性淋巴瘤发病率呈显著上升趋势,尤其是2014年至2019年日本的快速增长;然而,韩国在2011年至2015年期间没有显著增长。